GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » AcuCort AB (XSAT:ACUC) » Definitions » Loans Receivable

AcuCort AB (XSAT:ACUC) Loans Receivable : kr0.00 Mil (As of Mar. 2024)


View and export this data going back to 2017. Start your Free Trial

What is AcuCort AB Loans Receivable?

AcuCort AB's Loans Receivable for the quarter that ended in Mar. 2024 was kr0.00 Mil.


AcuCort AB Loans Receivable Historical Data

The historical data trend for AcuCort AB's Loans Receivable can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AcuCort AB Loans Receivable Chart

AcuCort AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Loans Receivable
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

AcuCort AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Loans Receivable Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

AcuCort AB Loans Receivable Calculation

Loans Receivable are the funds that a company has lent but have not yet been repaid.


AcuCort AB Loans Receivable Related Terms

Thank you for viewing the detailed overview of AcuCort AB's Loans Receivable provided by GuruFocus.com. Please click on the following links to see related term pages.


AcuCort AB (XSAT:ACUC) Business Description

Traded in Other Exchanges
N/A
Address
Kullagatan 8, Helsingborg, SWE, 252 20
AcuCort AB is an innovative biotechnology company that identifies, develops and commercializes smart drugs that meet the patient's needs for a user-friendly and effective treatment.

AcuCort AB (XSAT:ACUC) Headlines

No Headlines